baber/WOPTO huggingface dataset:
Patent NZ-531763-A (NZ)
Title: A method and system for asset tracking
Inventor: HAAVE LUTHER
IPC: H04W4/02
Filed: 2002-08-19
Abstract: An asset tracking and panic alarm system includes: a tracking device for mounting in an asset; a panic alarm pendant for carrying by a person; a RF receiver module for mounting in the asset for receiving a panic alarm signal from the pendant; and, a server coupled to a cellular telephone network and to a client terminal; the server including means for receiving the panic alarm indication and GPS information from the tracking device via the cellular telephone network; the server including means for determining a location of the asset from the GPS information; the client terminal for displaying the panic alarm indication and the location to a user, thereby notifying the user that the person has activated the panic alarm switch within a predetermined radius from the asset.
Patent NZ-533083-A (NZ)
Title: Method for recovering and purifying recombinant human erythropoietin (rhEpo) from a cell culture medium comprising host cells
Inventor: ALLIGER PETER
IPC: C12N15/09
Filed: 2002-11-26
Abstract: A method for recovering and purifying recombinant human erythropoietin (rhEpo) from a cell culture comprising host cells and the steps of: (a) removing host cells, cellular constituents and debris from the cell culture medium by performing a procedure selected from the group consisting of (i) centrifugation followed by a depth filtration step, (ii) a depth filtration step, and (iii) centrifugation, to obtain a clarified culture medium supernatant; (b) adjusting the conductivity of the supernatant to 5 mS/cm or less, and a pH of between about 7.0 and 8.0; (c) applying the supernatant from step (b) to a column comprising an anion exchange chromatographic medium, washing the column, eluting the rhEpo from the column, and collecting the peak fraction(s) that contain rhEpo; (d) subjecting the combined peak fractions from step (c) to a reverse phase chromatography step using a resin that can be run under medium pressure (< 10 bar) and is resistant to high concentrations of NaOH, the rhEpo being eluted using a linear gradient of an organic solvent. (e) applying one or more fractions eluted in step (d) which contain rhEpo to a column comprising anion exchange chromatographic media, washing the column, and eluting the rhEpo using a linear salt gradient; (f) selecting one or more fractions eluted in step (e) which contain rhEpo based on degree of sialylation of the rhEpo; and (g) subjecting one or more fractions eluted in step (f) which contain rhEpo by one or more size exclusion chromatographic steps using a gel filtration medium to remove potential dimers and higher aggregates; and collecting the eluate containing rhEpo.
Patent NZ-533417-A (NZ)
Title: The method of treating cancer
Inventor: KHAMAR BAKULESH MAFATIAL
IPC: A61K35/74
Filed: 2002-12-10
Abstract: A method of treating cancer is disclosed using a pharmaceutical composition made from "Mycobacterium w' (Mw) is found to be useful in the management of cancer.. The use of Mycobacterium w containing formulations is associated with decrease in burden of cancer tissue, decreasing symptoms associated with cancer and improving quality of life. It also improves tolerance to other therapies.
Patent NZ-539714-A (NZ)
Title: Non-competitive immunoassay for small analytes
Inventor: PULLI TIMO
IPC: G01N33/68
Filed: 2003-11-17
Abstract: Disclosed is a non-competitive immunoassay for small analytes, wherein the analyte is reacted with two binding partners. The first binding partner binds to the analyte to form a complex between the first binding partner and the analyte, and the second binding partner binds to the complex formed by the first binding partner and the analyte. The resulting complex formed between the analyte and the binding partners is detected. The binding partners are proteins, such as antibodies including antibody fragments. Also disclosed are reagent pairs and test kits useful in the assays, as well as the use of the reagent pairs and the process for their preparation. Novel reagents and means for their preparation are also provided.
Patent NZ-541954-A (NZ)
Title: Method of manufacturing a tamper-resistant marker
Inventor: BURLANDO ALBERT A
IPC: E01F9/669
Filed: 2005-08-22
Abstract: A tamper-resistant marker includes a blank of metal sheet material in the form of a plane having a perimeter and two faces. A flange extends about the perimeter in a direction substantially perpendicular to the faces. One face of the metal blank has a rim raised in a direction opposite to that of the flange and forming a depression on the face. A label bearing a message to be posted using the marker is disposed in the depression and covered with a coating of polyurethane forming a dome over the label.
Patent NZ-543676-A (NZ)
Title: Guttering mounting bracket with clips arranged to correspond to desired fall of guttering
Inventor: HIGGINS BRIAN JOHN
IPC: E04D13/072
Filed: 2004-04-15
Abstract: A mounting bracket for a gutter (20) for buildings, the gutter including a generally channel or trough shaped body for collecting water with an internal wall (23) having mounting means (24) thereon, the mounting bracket including an elongated bracket body which includes an attachment section (14) which is attachable to the building and a gutter mounting section (15), the gutter mounting section including a plurality of gutter support elements (26) arranged along the gutter mounting section and aligned so as to correspond to a fall required when the gutter is in an installed position.
Patent NZ-551697-A (NZ)
Title: Process and apparatus for plasma coating, substrates coated by this method or apparatus
Inventor: GOODWIN ANDREW JAMES
IPC: A01N33/12
Filed: 2005-05-13
Abstract: Disclosed is a method for forming an active material containing coating on a substrate, said method comprising the steps of: i) introducing one or more gaseous or atomised liquid and/or solid coating- forming materials which undergo chemical bond forming reactions within a plasma environment and one or more active materials which substantially do not undergo chemical bond forming reactions within plasma environment, into an atmospheric or low pressure non-thermal equilibrium plasma discharge and/or an excited gas stream resulting therefrom, and ii) exposing the substrate to the resulting mixture of atomised coating forming and at least one active material which are deposited onto the substrate surface to form a coating. Also disclosed is a coating substrate obtained by said method and the use of said coated substrate in the manufacture of a medicament for a therapeutic application.
Patent NZ-555121-A (NZ)
Title: 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
Inventor: HAUPT ANDREAS
IPC: A61K31/18
Filed: 2005-10-14
Abstract: Disclosed is a 6-amino(aza)indane compound of the formula Iwherein Ar is phenyl or an aromatic 5- or 6-membered C-bound heteroaromatic radical, wherein Ar carries 1 radical Ra. Ra being selected from the group consisting of alkyl, alkenyl, fluorinated alkenyl, cycloalkyl, X is N or CH; E is CR6R7 or NR3; R1 is alkyl, cycloalkyl, cycloalkylmethyl, alkenyl, fluorinated alkyl, fluorinated cycloalkyl, fluorinated cycloalkylmethyl, fluorinated alkenyl, formyl or alkylcarbonyl; R1a is H or R1a and R2 or R1a and R2a together are (CH2)n with n being 1, 2, 3 or 4; R2and R2a each independently are H, CH3, CH2F, CHF2 or CF3; R3 is H or alkyl; R4, R5 independently of each other are selected from H, alkyl, alkoxy and fluorinated alkyl; R6, R7 independently of each other are selected from H, alkyl and fluorinated alkyl and the physiologically tolerated acid addition salts of these compounds. Also disclosed is a composition compromising said compound and the use of said compound in the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand e.g. a disease of the central nervous system i.e. depression.
Patent NZ-556252-A (NZ)
Title: Electrochemical cell with improved internal contact
Inventor: KAPLIN DAVID
IPC: H01G15/00
Filed: 2006-01-25
Abstract: Disclosed is an electrochemical battery cell comprising of a housing, an electrode assembly and an electrolyte. The electrode assembly comprises a negative electrode strip, a positive electrode strip and at least one separator strip disposed between the negative and positive electrodes. The housing comprises a container having at least one side wall and a bottom wall. The electrode assembly has an electrically nonconductive external side surface adjacent to the container side wall and a bottom adjacent to the container bottom wall. One of the negative and positive electrodes is in electrical contact with the container side wall through an electrical lead extending from the electrode assembly and folded along the side of the electrode assembly, so at least a portion of the lead is disposed between the electrode assembly side surface and the container side wall. The lead is in physical contact with the container side wall by pressure only. The portion of the lead between the electrode assembly side surface and the container side wall comprises a deformed initially non-planar shape that is biased against an internal surface of the container side wall.
Patent NZ-560200-A (NZ)
Title: Portable toilet
Inventor: BURCOMBE MELVYN LESLIE
Filed: 2007-07-27
Abstract: A portable toilet for use in an emergency or disaster situations is disclosed. The toilet includes a toilet seat (2) and a bag (7) that is attachable to the under surface of the seat. The seat can be releasably attached to and positioned on to the top of containers (6) of differing mouth diameters by the use of at least two spaced apart container receiving recesses (5) on the under surface. The bag fits within the container to collect toilet waste.
Patent NZ-562093-A (NZ)
Title: Antibody neutralizers of human granulocyte macrophage colony stimulating factor
Inventor: RAUM TOBIAS
IPC: C07K16/24
Filed: 2006-04-18
Abstract: Provided is a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF, wherein said human monoclonal antibody or fragment thereof specifically binds to an epitope of primate GM-CSF comprising amino acids 23-27(RRLLN) and amino acids 65-77 (GLR/QGSLTKLKGPL). Further provided are specific protein and DNA sequences for such antibodies and their uses in the manufacture of medicaments for various diseases.
Patent NZ-562334-A (NZ)
Title: Lactose-positive recombinant leuconostoc strain
Inventor: JENSEN PETER RUHDAL
IPC: A23L3/3571
Filed: 2006-03-15
Abstract: Provided is the use of a lactose-positive Leuconostoc carnosum strain comprising genes encoding: a lactose transporter and a beta-galactosidase or beta-glucosidase in the production of a milk product. Further provided are corresponding isolated bacterial strains, starter cultures and milk products containing the strain and methods of producing milk products using the strains as well as products produced using the strains.
Patent NZ-563461-A (NZ)
Title: Audio codec post-filter
Inventor: SUN XIAOQIN
IPC: G10L25/93
Filed: 2006-04-05
Abstract: A computer-implemented method for calculating a set of filter coefficients for application to a reconstructed audio signal, a method for processing a reconstructed audio signal, and a method for processing a reconstructed composite signal is disclosed. The method for calculating a set of filter coefficients comprises: (a) performing a transform of a set of initial time domain values from a time domain into a frequency domain to produce a set of initial frequency domain values; (b) performing one or more frequency domain calculations using the initial frequency domain values to produce a set of processed frequency domain values; (c) performing a transform of the processed frequency domain values from the frequency domain into the time domain to produce a set of processed time domain values; and (d) producing a filtered audio signal by filtering at least a portion of the reconstructed audio signal in a time domain using the set of filter coefficients. Performing one or more frequency domain calculations using the initial frequency domain values to produce a set of processed frequency domain values comprises clipping frequency domain values in the frequency domain.
Patent NZ-568045-A (NZ)
Title: Wear assembly for excavating machines
Inventor: MCCLANAHAN ROBERT
IPC: E02F9/28
Filed: 2006-08-28
Abstract: A wear cap 12 for the entry edge of an excavating blade is provided with top and bottom legs 76, 78 extending rearwardly from the front portion 74 of the cap and defining a cavity 90 to receive the digging edge 52 of the blade. The front end 14 of the cavity is defined by upper and lower surfaces 96, 98 and a front abutting surface 92 which respectively overlie and bear against corresponding walls of the digging edge to resist loads applied during digging. The upper and lower surfaces 96, 98 are inclined in the same direction relative to a central plane 59 of the digging edge and the lower surface 98 faces toward the front abutting surface 92. The cavity is laterally open rearward of the front end to accommodate a wider lateral extension of the digging edge beyond the legs. An opening for receiving a lock 16 to hold the wear cap to the digging edge is provided.
Patent NZ-568546-A (NZ)
Title: Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
Inventor: DEANS ROBERT
IPC: A61K35/14
Filed: 2006-11-09
Abstract: Disclosed is the use of multipotent cells in the manufacture of a medicament for adjunctive treatment of a subject at risk for or suffering from an immune dysfunction, wherein the cells: are not embryonic stem cells, embryonic germ cells, or germ cells; can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal embryonic lineages; express telomerase; do not provoke a deleterious immune response in the subject; are effective to treat the immune dysfunction in the subject; wherein the medicament is to be administered adjunctively to another treatment to the subject to treat the same thing, to treat something different or both, or the medicament comprises at least one other agent to treat the immune dysfunction, to treat another condition or both.
Patent NZ-569408-A (NZ)
Title: Granular material comprising water-insoluble inorganic phosphate binders
Inventor: PENNELL RUTH DIANE
IPC: A61K33/244
Filed: 2007-01-30
Abstract: Disclosed is a granular material comprising -at least 50 percent by weight based on the weight of the granular material of solid water-insoluble inorganic mixed metal compound capable of binding phosphate and which contains iron (III) and at least one of magnesium, calcium, lanthanum or cerium -from 3 to 12 percent by weight based on the weight of the granular material of nonchemically bound water, and -no greater than 47 percent by weight based on the weight of the granular material of excipient. Also disclosed is a process for preparing the said granular material comprising the steps of -mixing the solid water-insoluble inorganic mixed metal compound with one or more excipients to produce a homogeneous mix, -contacting a suitable liquid with the homogeneous mix and mixing in a granulator to form wet granules, -optionally passing the wet granules though a screen to remove granules larger than the screen size, -drying the wet granules to provide dry granules -milling and/or sieving the dry granules. Also disclosed is the use of the said granular material in the manufacture of a medicament for binding phosphate.
Patent NZ-578627-A (NZ)
Title: Spraying apparatus
Inventor: SMALL GREGORY
IPC: B05B7/24
Filed: 2009-07-27
Abstract: A spray delivery unit 2 for dispensing a chemical formulation onto a crop includes first and second air outlets 5, 7 joined at the base 8 through which pressurized air is emitted and diverging at an acute angle from each other so that the pressurized air emitted from the outlets diverges from the outlets at the acute angle. A pair of spray jets 16 is attached to each outlet to emit pressurized chemical formulation into the vicinity of the outlets between the acute angle. The pressurized air directed over the crop from the first and second outlets creates a turbulent air stream into which the spraying liquid from the spray jets is drawn and entrained so as to dispense droplets of the chemical formulation over and throughout the crop.
Patent NZ-579374-A (NZ)
Title: Novel dosage form comprising 1-{ 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl} -2-pyrrolidinone
Inventor: CLARKE ALLAN JAMES
IPC: A61K9/20
Filed: 2008-02-28
Abstract: Disclosed is a solid oral dosage form which comprises a carrier tablet, which carrier tablet is at least partially covered by a film comprising a) 1-{ 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl} -2-pyrrolidinone or a pharmaceutically acceptable salt thereof, and b) a stabiliser that reduces degradation of 1-{ 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl} -2-pyrrolidinonein the dosage form, when compared to a dosage form lacking said stabiliser; wherein said stabiliser is selected from the group consisting of citric acid, malic acid, ascorbic acid and its salts, sodium bicarbonate, butylated hydroxyanisole and butylated hydroxy toluene for the treatment of neurological diseases.
Patent NZ-582799-A (NZ)
Title: A ducting arrangement for a water heater
Inventor: GIBSON CAMERON
IPC: F24H1/00
Filed: 2010-01-22
Abstract: A combustion water heater comprising a tank 9.002 with a base 9.004, a fuel burner located so that the combustion products impinge directly on the base 9.004 of the tank 9.002 and a cowling 9.010 through which the combustion products pass, placed directly below the base 9.004 of the tank 9.002. The cowling's shape corresponds substantially to that of the base of the tank. The cowling provides a non- linear baffle arrangement as a combustion products path between the base of the tank and the cowling. This combustion products path ensures that a substantial portion of the combustion products are maintained in proximity to the base of the tank while the water in the tank is being heated.
Patent NZ-583186-A (NZ)
Title: Pyrimidinyl-pyridazinone derivatives
Inventor: SCHADT OLIVER
IPC: C07D403/14
Filed: 2008-07-04
Abstract: The disclosure relates to salts of pyrimidinyl pyridazinone derivates, particularly disclosed are sulphate, mesylate, besylate, p-tosylate, fumarate and maleate salts of 6-(1-Methyl-1H-pyrazol-4-yl)-2-{ 3-[5-(2-morpholin-4-ylethoxy)-pyrimidin-2-yl]benzyl} -2H-pyridazin-3-one; and hydrochloride monohydrate, hydrobromide, mesylate, besylate, malate, p-tosylate, fumarate and maleate salts of 3-(1-{ 3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2-yl]-benzyl} -6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile. These compounds are inhibitors of tyrosine kinases, especially of Met kinase, and can be used, inter alia, for treatment of tumours, where the solid tumour originates from the group of tumours of the squamous epithelium, the bladder, the stomach, the kidneys, of head and neck, the oesophagus, the cervix, the thyroid, the intestine, the liver, the brain, the prostate, the urogenital tract, the lymphatic system, the stomach, the larynx and/or the lung, and also where the solid tumour originates from the group monocytic leukaemia, lung adenocarcinoma, small-cell lung carcinomas, pancreatic cancer, glioblastomas and breast carcinoma.
Patent NZ-583718-A (NZ)
Title: Grippers for use in palletising packaged goods
Inventor: BRYANT CRAIG
IPC: B25J9/02
Filed: 2008-12-09
Abstract: A gripper (6) for mounting on a robotic arm (not shown) comprising a support structure (600) adapted for attachment to the robotic arm incurring opposed fork assemblies (602, 603) adapted for movement towards and away from each other to support or release layers of packaged goods, and opposed load clamping/squaring members (604, 605, 606, 607) mounted on the support structure for movement towards and away from each other to square and align the layer to be transferred by the gripper and for upward and downward movement to allow the layer to be transferred or be squared or aligned with a previously palletised layer. (62) Divided Out of 573497
Patent NZ-584190-A (NZ)
Title: Once-a-day replacement transdermal administration of fentanyl
Inventor: HWANG STEPHEN S
IPC: A61F13/00
Filed: 2008-10-15
Abstract: Disclosed is a transdermal patch for administering fentanyl, comprising an adhesive fentanyl reservoir on a backing layer, the reservoir having a thickness of 0.0125 mm (0.5 mil) to 0.0375 mm (1.5 mil) disposed on the backing layer, at least the skin contacting surface of the reservoir being adhesive; the reservoir comprising a polyacrylate adhesive containing about 7 to about 12% by weight and about 0.14 to 0.3 mg/cm2 of fentanyl per area of the reservoir, wherein the thickness and area of said reservoir and said concentration of fentanyl being such that the fentanyl in said reservoir is sufficient to induce and maintain analgesia in a human for about one day, but not to induce and maintain analgesia for three days. The patch is useful for the treatment of pain.
Patent NZ-588793-A (NZ)
Title: Non-aqueous electrolyte comprising linear asymmetric ethers for use in lithium primary batteries
Inventor: HUANG WEIWEI
IPC: H01M6/16
Filed: 2009-04-22
Abstract: A non-aqueous electrolyte for a primary electrochemical cell, such as a lithium/iron disulfide cell is disclosed, wherein the electrolyte consists essentially of at least one solute (preferably lithium iodide) dissolved in a solvent blend of 1,3-dioxolane, 1,2-dimethoxyethane and 1-ethoxy-2-methoxyethane, wherein at least 10 vol. % of the solvent blend is 1,2-dimethoxyethane, at least 10 vol. % of the solvent blend is 1-ethoxy-2-methoxyethane and at least 40 vol. % of the solvent blend is 1,3-dioxolane.
Patent NZ-590468-A (NZ)
Title: Treatment of inflammatory bowel diseases with human beta defensin proteins 1-4
Inventor: KJAER TANJA MARIA ROSENKILDE
IPC: A61K38/17
Filed: 2009-07-17
Abstract: Discloses the use of human beta defensin peptides (1-4), encoded by SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4, in the manufacture of a medicament adapted for parenteral administration in the treatment of an inflammatory bowel disease. The medicament may be administered subcutaneously or intravenously in a daily dosage from 0.001 mg/kg body weight to about 10 mg/kg body weight, where the use of the medicament results in a reduction of TNF-alpha activity is reduced in the treated tissues.
Patent NZ-591820-A (NZ)
Title: Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors
Inventor: FELDING JAKOB
IPC: A61P35/00
Filed: 2009-08-27
Abstract: 591820 Disclosed are amides and thioamides of formula I. Specific examples of compounds of formula I include: (4-{ [2-(3,3-Dimethyl-butylcarbamoyl)-phenylamino]-methyl} -pyridin-2-yl)carbamic acid methyl ester, 2-[(2-Acetylamino-pyridin-4-ylmethyl)-amino]-N-(3-ethyI-pentyl)-benzamide, Furan-2-carboxylic acid (4-{ [2-(4-methyl-pentylcarbamoyl)-phenylamino]-methyl} -pyridin-2-yl)-amide, and Furan-2-carboxylic acid (4-{ [2-(3-ethyl-pentylcarbamoyl)-phenylamino]-methyl} -pyridin-2-yl)-amide. Compounds of formula I exhibit a high receptor tyrosine kinase inhibitory activity on the receptor VEGFR-2, also referred to as the KDR receptor. The compounds inhibit angiogenesis, which is beneficial for treating diseases such as atherosclerosis, inflammatory conditions such as dermatitis, psoriasis, rosacea and rheumatoid arthritis, eye diseases such as diabetic retinopathy and macular degeneration, and cancer.